Connor, Clark & Lunn Investment Management Ltd. Amicus Therapeutics, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 222,934 shares of FOLD stock, worth $2.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

222,934

Previous 147,127 51.52%

Holding current value

$2.18 Million

Previous $1.46 Million 63.13%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$9.55 - $12.09 $723,956 - $916,506	75,807 Added 51.52%	222,934 $2.38 Million
Q2 2024 Aug 09, 2024	BUY	$9.04 - $11.75 $1.33 Million - $1.73 Million	147,127 New	147,127 $1.46 Million
Q4 2023 Feb 09, 2024	BUY	$9.97 - $14.52 $459,975 - $669,894	46,136 Added 71.5%	110,665 $1.57 Million
Q3 2023 Nov 13, 2023	BUY	$11.78 - $13.86 $136,388 - $160,471	11,578 Added 21.87%	64,529 $784,000
Q2 2023 Aug 10, 2023	BUY	$10.72 - $13.3 $194,814 - $241,700	18,173 Added 52.25%	52,951 $665,000
Q1 2023 May 09, 2023	BUY	$10.91 - $13.54 $379,427 - $470,894	34,778 New	34,778 $385,000
Q2 2022 Aug 05, 2022	BUY	$6.23 - $11.12 $689,361 - $1.23 Million	110,652 New	110,652 $1.19 Million
Q1 2021 May 13, 2021	SELL	$9.2 - $23.86 $993,066 - $2.58 Million	-107,942 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $1.45 Million - $2.69 Million	107,942 New	107,942 $2.49 Million
Q2 2018 Aug 02, 2018	SELL	$13.13 - $17.09 $151,178 - $196,774	-11,514 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$13.76 - $17.12 $1.99 Million - $2.48 Million	-144,812 Reduced 92.63%	11,514 $173,000
Q4 2017 Feb 09, 2018	SELL	$12.51 - $16.24 $3.38 Million - $4.39 Million	-270,263 Reduced 63.35%	156,326 $2.25 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $4.75 Million - $6.39 Million	404,839 Added 1861.33%	426,589 $6.43 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,750	21,750 $219,000

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Amicus Therapeutics, Inc. Transaction History